Evidence map›Paper›PMID 40884252›Full record

ReviewInternational immunology2026

Molecular mechanisms for direct sensing of virus-like antigens by B cells.

Wei Cheng, Julie Zikherman

Abstract readReview
In one paragraph

Review in International immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Protection AgainstPharmaceutics · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Wei ChengDepartment of Pharmaceutical Sciences, College of Pharmacy, University of Michigan, 428 Church Street, Ann Arbor, MI 48109, USA.
Julie ZikhermanDivision of Rheumatology, Department of Medicine, Rosalind Russell and Ephraim P. Engleman Arthritis Research Center, UCSF Medical Center, San Francisco, CA 94143, USA.ORCID 0000-0002-0873-192X

Funding

Mechanisms of B Cell Responses to Particulate AntigensR01AI155653 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CHENG, WEI, ZIKHERMAN, JULIE · 2021 to 2025
$3.6M
Nuclear Receptors in B Cell Tolerance and Humoral Immune ResponsesR01AI148487 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ZIKHERMAN, JULIE · 2020 to 2024
$2.0M
NIAID NIH HHS R01 AI148487NIAID NIH HHS R01 AI155653
6 · The paper itself

Abstract

Particulate antigens (Ags) such as viruses can often induce strong B-cell responses in vivo very effectively, but the molecular determinants of this complex process remain incompletely understood. In this review, we focus on recent mechanistic insights into the earliest steps in the initiation of primary B-cell responses to viruses, gained by exploiting a new generation of model particulate Ag, synthetic virus-like structures. We also review the characteristics of the resulting short- and long-term antibody (Ab) responses in mice. These studies reveal that a repeating pattern of epitope display on a virus-sized scaffold is a fundamental biophysical feature of viruses that triggers a qualitatively distinct mode of B-cell Ag receptor (BCR) signal transduction relative to soluble Ag display, and consequently serves as a standalone danger signal for Ag-specific B-cell activation. Quantitative variation in epitope density (ED) on such scaffolds modulates the degree and quality of B-cell activation both in vitro and in vivo. The presence of internal nucleic acid (iNA) in the interior of these virus-like structures can profoundly influence the resulting Ab responses for the lifespan of immunized animals. We conclude that the ED of viral surface Ags and the iNA genomes provide two essential signals that together are sufficient for B-cell activation and Ab production during antiviral responses. We place these findings in the context of the literature, discuss implications for rational vaccine design, and highlight unanswered questions to guide future research directions.

Indexed as

Antigens, ViralB-LymphocytesAnimalsHumansLymphocyte ActivationMiceReceptors, Antigen, B-CellAntigens, ViralReceptors, Antigen, B-CellBCRepitope densityparticulate antigenTLRvalency

Identifiers

PMID40884252
PMCPMC13327809

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.